Scandion Oncology A/S is a listed Danish biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. The company's first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has several preclinical programs to build a broader pipeline of drugs for the treatment of drug resistant cancer diseases.
View Top Employees from Scandion Oncology| Website | http://www.scandiononcology.com |
| Employees | 19 (19 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Medical, Health Care, Pharmaceutical |
Looking for a particular Scandion Oncology employee's phone or email?
Scandion Oncology Questions
Bo Hansen is the President and Chief Executive Officer of Scandion Oncology.
19 people are employed at Scandion Oncology.
Top Scandion Oncology Employees
-
35+
-
23
-
22
-
22
-
View
Nicklas Roest
Chief Regulatory Officer at Scandion Oncology
Copenhagen, Capital Region, Denmark2
Related Companies
